NCT00773994

Brief Summary

This prospective research study seeks to determine how the normal velopharyngeal mechanism compares, both anatomically and physiologically, with previous data obtained on subjects with submucous cleft palate (SMCP) in IRB#07080395.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 15, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 16, 2008

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2015

Completed
Last Updated

October 18, 2017

Status Verified

October 1, 2017

Enrollment Period

7.2 years

First QC Date

October 15, 2008

Last Update Submit

October 17, 2017

Conditions

Keywords

anterior palatal eminencepalatal elevation above the maxillary planeanterior uvular prolapse"inverted-V" present in base view.

Outcome Measures

Primary Outcomes (1)

  • Normalnormal velopharyngeal mechanism vs abnormal

    2 years or 10 subjects.

Study Arms (1)

Normal velopharyngeal mechanism

OTHER

All participants in this study are normal healthy adults, who have agreed to undergo to a videofluoroscopic Televex. These participants are acceptable control subjects because they are not diagnosed with VPI and/or submucous cleft palate (SMCP) and the velopharyageal mechanism functions the same in adults as it does in children. This procedure will take approximately 3 minutes to 5 minutes.

Other: Normal Velopharyngeal Mechansim

Interventions

The amount of radiation exposure that you will receive from this procedure is about 0.3 rem to the head and neck, with minimal exposure of the other body areas.

Normal velopharyngeal mechanism

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All subjects for this study are adults.
  • In this study, the most significant risk is that of radiation exposure, which for Televex videofluoroscopy, is comparable to a single undergoing a single x-ray study, and is significantly less than most CT scans.
  • There are no risks to a fetus or pregnant subject involved in this study, nor are there any interventions involved in the research that may be associated with reproductive risks, because all female participants will be given a urine pregnancy test prior to undergoing the Televex Videofluoroscopy.
  • All participants will wear protective lead torso and pelvic shields, which are standard for all personnel in a room where a radiologic evaluation is being performed.

You may not qualify if:

  • The subjects for this study are all adult.
  • None of the participants will be children because we are looking for subjects who have reached skeletal maturity which happens around the age of 18 years old
  • Any positive urine pregnancy test results would exclude the female subject from this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Cleft Palate

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesMouth AbnormalitiesMouth DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Jennifer Szczepaniak, BS

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ross H. Musgrave Professor of Pediatric Plastic Surgery Executive Vice-Chair and Program Director Department of Plastic Surgery University of Pittsburgh Medical Center

Study Record Dates

First Submitted

October 15, 2008

First Posted

October 16, 2008

Study Start

May 1, 2008

Primary Completion

July 1, 2015

Study Completion

July 15, 2015

Last Updated

October 18, 2017

Record last verified: 2017-10

Locations